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Abstract 
 
Ravilla, Nagendra Babu. M.S. Department of Pharmacology and Toxicology, Wright 
State University, 2013.K-Cl cotransport: Role of KCC3 in cellular potassium (K) 
homeostasis in KCC3-transfected HEK-293 cells. 
 
     K-Cl cotransport (KCC) mediated by four protein isoforms, KCC1 to KCC4, plays a 
significant role in cell volume regulation, and in K and Cl homeostasis. In this study, we 
demonstrate the importance of KCC3 and its two threonine (T) phosphorylation sites  
T991 and T1048 in cellular K homeostasis in isogenic human embryonic kidney (HEK-
293) cells transfected with KCC3 wild type (WT) or constitutively active double mutant 
KCC3 (AA) expressed under tetracycline or doxycycline control. In both WT and AA 
cells, under baseline conditions, the Na-K-2Cl cotransport (NKCC) (55 %- 60 %) was the 
major contributor of Rb influx followed by the Na/K pump (NKP) (35 % - 40 %) and 
KCC (10 % - 15 %) even though the absolute values of Rb influx  were higher in AA 
cells. Doxycycline induction had no effect on either NKCC or KCC in WT cells, whereas 
NKCC was completely inhibited and KCC was increased by 25 fold in AA cells. In AA 
cells, intracellular K (Ki) decreased by 90 % upon doxycycline induction in Cl medium 
and 50 % of this loss was attenuated in Cl-free (sulfamate replacement) medium. 
Doxycycline-induced Cl-dependent Ki loss  was sensitive to furosemide (2 mM) but 
insensitive to tetra ethyl ammonium (TEA) (2 mM) and to changes in external K and Na, 
whereas doxycycline-induced Cl-independent Ki loss was sensitive to 4-(2-butyl-6,7-
dichloro-2-cyclopentylindan-1-on-5-yl)oxybutyric acid (DCPIB) (50 µM) but insensitive 
to TEA (2 mM), furosemide (2 mM) and extracellular K and Na. 
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1. Introduction 
Regulation of cell volume is vital for cell survival. Lacking a rigid cell wall, 
animal cells are more vulnerable to changes in extracellular or intracellular osmolality; 
except in a few cell types, the cell membrane is highly permeable to water. However, 
compared to the water permeability, the cell membrane’s permeability to Na
+
, K
+
 and Cl
-
 
is orders of magnitude lower. Thus to maintain a stable cell volume, both prokaryotic and 
eukaryotic cells have evolved with numerous transporter proteins that transport Na
+
, K
+
 
and Cl
-
 across the plasma membrane. Regulation of these transporters is a highly 
complicated physiological phenomenon involving several physical, chemical and 
biological factors that act harmoniously with the ultimate aim to preserve membrane 
integrity and cell volume.  
According to the “pump and leak” hypothesis [8], cell swelling and lysis are 
avoided by a limited permeability of the plasma membrane to Na, and by a continuous 
Na-K-ATPase activity, which pumps Na out and K in. Most cells effectively counteract 
changes in cell volume following perturbation in intracellular or extracellular osmolality 
either by regulatory volume increase (RVI) or regulatory volume decrease (RVD) in 
which several transporters and channels are involved [14, 48].  
In osmotically swollen cells, K, Cl and other nonessential organic osmolytes exit 
the cell followed by water, and this leads to the recovery of cell volume. This mechanism 
is called RVD, which involves volume-sensitive Cl and K channels along with electro- 
neutral KCC. In contrast, when a cell shrinks due to osmotic shock, Cl, K and Na enter 
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the cell followed by water and thus restore the cell volume. This mechanism is defined as 
RVI, which involves the Na/H exchanger, NKCC, and non-selective cation channels [14].
  
In this study, we explore the role of KCC in K and Cl homeostasis and cell 
volume regulation in a human epithelial cell line by using KCC3 wild type (WT) and 
KCC3 mutant (AA) transfected human embryonic kidney (HEK-293) cells. Before 
providing a more detailed description of the study, a brief introduction about K-Cl 
cotransport and its regulation and significance will be presented.  
1.1. K-Cl cotransport (KCC) 
KCC is a secondary active transport that extrudes K and Cl out of the cell, 
preserving intracellular Cl and K homeostasis and thus cell volume. This transport system 
was first identified as an N-ethylmaleimide (NEM) - and swelling activated K efflux in 
low K sheep red blood cells [42, 44]. It is encoded by four genes SLC12A4 to 7 and thus 
has four protein isoforms KCC1 to KCC4 with splice variants in each isoform. KCC1, 
being present in all the tissues, is considered as housekeeping KCC isoform [5, 38], 
whereas KCC2 is mainly restricted to the central nervous system [18, 38], even though 
recent studies confirmed its presence in lens epithelial cells [43], retinal neurons [20, 38] 
and cervical cancer cells [59]. More recently, a second spliced variant of KCC2 has been 
reported [52]. Therefore, the originally published KCC2 of the then neuronal system is 
now the KCC2b variant, whereas the second and longer variant KCC2a occurs not only in 
the brain but also in other tissues [47, 52]. KCC3 presence was reported for brain, heart, 
 3   
 
skeletal muscle and kidney [7, 25, 38]. KCC3 has NH2 – terminal heterogeneity with two 
major isoforms, a longer KCC3a, and shorter KCC3b, which are highly expressed in 
kidney (1). The KCC4 protein was discovered in several tissues like bone marrow, spleen, 
thymus, spinal cord, brain, prostrate, pancreas, liver, skeletal muscle, heart lung and the 
basolateral membranes of the nephron [7, 38]. The main function of these transporters is 
regulation of cell volume by RVD [48]. When the extracellular milieu becomes 
hypoosmotic, water enters the cell resulting in increased cell volume. This increased cell 
volume activates the volume-sensitive K and Cl channels along with KCCs and extrudes 
the K and Cl ions followed by water to bring the cell back to its original volume [48]. 
1.2. Significance of KCC 
Besides regulating the cellular volume, KCC has been implicated in several 
pathologies and in cell growth and migration. Several reviews give us a clear idea about 
the importance of KCC in sickle cell disease, cardiovascular pathology, epileptic seizures 
and tumor biology [39, 10, 11, 21, 57]. Numerous studies have shown the importance of 
KCC1 in cellular dehydration of red blood cells (RBCs) in homozygous sickle cell 
disease [45, ref. in].  
KCC2 being neuron specific has been reported to play an important role in 
deciding the neurotransmitters GABAA and glycine function. During early fetal life, 
GABAA and glycine act as excitatory neurotransmitters due to high intracellular Cl (Cli) 
whereas in adult neuron, expression of KCC2 results in decreased Cli and this leads to 
inhibitory action of GABAA and glycine [3, 6, 10]. KCC2 knockout mice cannot live and 
die of respiratory failure [19]. Heterozygous mice with reduced KCC2 expression are 
susceptible to hyper-excitability and epileptic seizures demonstrating the role of KCC2 in 
epilepsy [41].  
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Mutations in KCC3 are involved in an autosomal recessive syndrome called 
Anderman syndrome in which agenesis (A) of carpus (C) callosum (C) is accompanied by 
a peripheral (P) neuropathy (N) (ACCPN) [17], which is mostly seen in the French-
Canadian population of the Quebec region of Canada. People with this disorder suffer 
from areflexia, hypotonia, amyotrophy and tremors due to improper development of 
certain cranial nerves. KCC3 knockout mice exhibit arterial hypertension [30, 40]. KCC3 
knock out in mice also results in progressive neurodegeneration, deafness and decreased 
threshold for seizure or epilepsy [55]. A study in KCC3-transfected NIH/3T3 fibroblasts 
shows the role of this transporter in cell growth and proliferation [34]. Recent studies also 
exploit the role of KCC, and specifically KCC3 and KCC4, in cancer cell invasion and 
proliferation [58, 560, 59]. Besides its role in tumor biology, KCC4 is also important in 
acid-base balance because mutations in KCC4 result in renal tubular acidosis [54].  
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Table 1. K-Cl cotransport: Gene expression and significance (Modified from ref.21) 
 
Gene SLC12A4 SLC12A5 SLC12A6 SLC12A7 
Human 
Gene Locus 
16q22 20q13 15q14 5p15 
Protein KCC1 KCC2 KCC3 KCC4 
Isoforms 
and Amino 
Acid 
Residues 
1085 KCC2a-1075 
KCC2b-1115 
KCC3a-1150 
KCC3b-1099 
1083 
Tissue  
Expression 
Ubiquitous Neurons and 
other tissues 
Extensive Extensive; 
Limited in 
Brain 
Direct 
Disease 
Association 
- - ACCPN 
(Anderman 
Syndrome) 
- 
KO 
Phenotype 
No 
phenotype 
Death by 
respiratory 
failure, 
incomplete 
knock-out- 
epilepsy, 
death in 15 
days 
Hypertension, 
deafness, 
tumor biology 
Renal tubular 
acidosis, 
epilepsy, 
sickle cell 
anemia 
Importance 
in Complex 
Disease 
Sickle cell 
anemia? 
Epilepsy Renal tubular 
acidosis, 
epilepsy, 
sickle cell 
anemia 
Renal tubular 
acidosis, 
epilepsy, sickle 
cell anemia 
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1.3. Mechanisms regulating KCC 
The role of numerous signaling pathways in regulating KCC activity has been 
elucidated. Phosphorylation/dephosphorylation of the transporter through series of 
kinases/phosphatases is the major mechanism that regulates this transporter as initially 
proposed by Jennings [33]. Phosphorylation inhibits KCC and activates NKCC and vice 
versa via dephosphorylation. Studies during the last decade have elucidated the essential 
role of “with no lysine kinases” (WNKs) in the regulation of NKCC and KCC (26, 27, 28, 
29). NKCC regulation by WNK kinases via Ste20/Sps1-related proline/alanine rich 
kinase (SPAK) and the oxidative stress responsive kinase 1(OSR1) has been well 
explored compared to KCC regulation through these kinases (24, 11). Regulation of 
NKCC and KCC via these kinases and their role in cell volume regulation is shown in 
figure 1. Other major mechanisms include the regulation by the NO/cGMP/PKG pathway 
[31, 38] and PDGF-mediated pathway in vascular smooth muscle cells (VSMCs) [32, 36, 
38 and ref. in] and the phosphoinositol/PKC pathway in low-K sheep red cells which 
have KCC1 and KCC3 isoforms [4, 38]. 
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Figure 1. Model for cell volume regulation. Role of osmosensitive kinases 
and phosphatases and of NKCC, and KCC in cell volume regulation via RVI 
and RVD. Details are discussed in text. 
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Figure 2. Proposed KCC regulation mechanism by vasodilators in vascular smooth 
muscle cells. Vasodilators (VDs) such as sodium nitroprusside (SNP) release nitric oxide 
(NO) and activate the soluble guanylyl cyclase (sGC). The enzyme converts GTP into 
cGMP and this, in turn, activates protein kinase G (PKG) which, by an unknown 
mechanism, activates protein phosphatase 1 (PP1) and KCC. SNP and 8-Br cGMP, NO 
donor and PKG activator, respectively, stimulate the KCC, whereas sGC and PKG 
antagonists LY 83583 and KT 5823, respectively, inhibit KCC. (Redrawn from [36]) 
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Figure 3. Proposed mechanism of KCC regulation by platelet-derived growth factor 
(PDGF) in VSMCs. PDGF binds to its receptor and activates PI 3-K which, through an 
unknown mechanism, activates PP1, leading to dephosphorylation and activation of K-Cl 
COT. Involvement of the PDGF receptor was uncovered by inhibition with AG1296. 
Participation of PI 3-K was determined by inhibition with Wortmannin and LY294002. 
Finally, participation of PP1 was studied with calyculin A, a selective inhibitor of the 
phosphatase. (Redrawn from [36]). 
 
1.4. KCC3 structure 
As represented in figure.2, human KCC3 is a trans-membrane protein with 
KCC3a and KCC3b isoforms constituting 1150 and 1099 amino acid residues, 
respectively, with molecular weights of the un-glycosylated proteins of 130 and 125 kDa, 
respectively, possessing an intracellular short N-terminal and long C-terminal, and an 
extracellular loop connecting trans-membrane domains 5 and 6. KCC3 bears several 
glycosylation sites on its extracellular loop whose functions are still unknown. Recent 
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studies revealed that KCC3 has two functionally significant phosphorylation sites; 
threonine (T) 991 and 1048; their deletion or mutation perturb KCC activity [22]. 
 
 
Figure 4. Hypothetical model of KCC3 structure. KCC3 is reported to contain 12-
transmembrane domains, a larger extracellular loop between domains 5 and 6, and 
intracellular N- and C-terminal domains, in addition to phosphorylation and glycosylation 
sites. Details are discussed in the text. 
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2. Hypothesis and Specific Aims 
2.1. Background for hypothesis  
The two functionally important threonine (T) kinase phosphorylation sites in 
KCC3, T991 and T1048, are localized on its C-terminal. The double A substitution 
prevents phosphorylation, which inhibits KCC3 at these sites, and hence activates the 
transporter. Thus, the AA mutant mimics the dephosphorylated KCC3 that is present 
during RVD [22]. We detected permanent activation of KCC3 through increased Rb (K) 
influx. Preliminary data from our experiments showed that increased Rb (K) influx was 
associated with K loss in KCC3AA-transfected HEK-293 (AA) cells. Based on these 
data, we propose the following hypothesis. 
2.2. Hypothesis 
The threonine (T) phosphorylation sites T991 and T1048 on KCC3 are important 
for K-Cl cotransport regulation. Their replacement with alanine (A) permanently activates 
KCC3 as measured by Cl-dependent Rb influx and K-loss. Expression in HEK-293 cells 
of the AA-mutant KCC3 also may result in collateral stimulation of K loss mechanisms 
and perturb cellular K homeostasis. 
 12   
 
2.2.1. Specific Aim 1 
Characterize baseline and doxycycline-induced Rb (K) influx under physiological 
conditions in the presence and absence of Cl anions, and thus K-Cl cotransport, in WT 
and AA transfected HEK293 cells to determine whether AA cells are indeed permanently 
activated. 
2.2.2. Specific Aim 2 
Determine whether AA cells are indeed permanently activated by assessing the role of 
confounding factors such as external Na, serum deprivation and osmolality on Rb influx. 
2.2.3. Specific Aim 3 
Identify K loss mechanisms induced by doxycycline in AA cells utilizing ion substitution 
and a variety of chemical inhibitors of K, Cl and Ca channels. 
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3. Materials and Methods 
3.1. Chemicals  
Chemicals from Fisher Scientific (Fair lawn, NJ) were: Tri-hydroxyamino 
methane (Tris) free base, sodium chloride (NaCl), potassium chloride (KCl), magnesium 
chloride (MgCl2), sodium hydroxide (NaOH), sucrose, D-glucose, perchloric Acid, 70 % 
(PCA), and bicinchonic acid (BCA) protein assay reagents. Magnesium gluconate was 
from Sigma-Aldrich (St. Louis, MO). (4-(2-hydroxyethyl)-1-piperazine ethane sulfonic 
acid (HEPES) free acid, and calcium chloride (CaCl2), anhydrous were from J.T.Baker 
Chemical Co (Center valley, PA). Rubidium chloride (RbCl), 99.8 % (metals basis), and 
amidosulfonic acid (sulfamic acid, S), 99.99 % (metals basis) were purchased from Alfa 
Aesar (Ward Hill, MA); N-methyl D-glucamine (NMDG) from Fluka Biochemika (St. 
Louis, MO); Cesium chloride (CsCl) from Life technologies (Carlsbad, CA) and calcium 
gluconate from Acros Organics (NJ). 
3.2. Inhibitors 
Ouabain octahydrate was purchased from Calbiochem (San Diego, CA), 
furosemide and bumetanide from Sigma-Aldrich (St. Louis, MO), DCPIB from Tocris 
Bioscience (Bristol, UK), tetra ethyl ammonium (TEA) from Abcam (Cambridge, MA), 
clofilium tosylate from Enzo life sciences (Farmingdale, NY), and RN-1734 and 
Ruthenium Red from Santa Cruz Biotechnology (Santa Cruz, CA). 
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3.3. Solutions for flux studies 
Washing solutions 
Balanced salt solution (BSS-NaCl): 20 mM Hepes-Tris, 5 mM KCl, 2 mM CaCl2, 1mM 
MgCl2, 10 mM glucose and NaCl, pH
 
7.4, 37 
0
C, 300 mOsM. 
BSS-NaS: 20 mM Hepes-Tris, 5mM K sulfamate, 2 mM Ca gluconate, 1 mM Mg 
gluconate, 10 mM glucose and NaS. pH
 
7.4, 37 
0
C, 300 mOsM. 
Pre-incubation solutions 
BSS-NaCl-BSA: 20 mM Hepes-Tris, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM 
glucose, 0.1 % BSA and NaCl, pH
 
7.4, 37 
0
C, 300 mOsM. 
BSS-NaS-BSA: 20 mM Hepes-Tris, 5 mM K sulfamate, 2 mM Ca gluconate, 1 mM Mg 
gluconate, 10 mM glucose, 0.1 % BSA and NaS. pH
 
7.4, 37 
0
C, 300 mOsM. 
Flux solutions 
BSS-RbCl-NaCl-BSA: 20 mM Hepes-Tris, 10 mM RbCl, 2 mM CaCl2, 1 mM MgCl2, 10 
mM glucose, 0.1 % BSA and NaCl, pH
 
7.4, 37 
0
C, 300 mOsM. 
BSS-RbS-NaS-BSA: 20 mM Hepes-Tris, 10 mM Rb sulfamate, 2 mM Ca gluconate, 1 
mM Mg gluconate, 10 mM glucose, 0.1 % BSA and NaS. pH
 
7.4, 37 
0
C, 300 mOsM. 
Final wash solution 
10 mM MOPS-Tris, MgCl2, pH 7.4, 37 
0
C, 300 mOsM. 
Rb Extraction  
5 % perchloric acid, 4 mM CsCl 
Protein dissolution 
1M NaOH 
 
 
 15   
 
3.4. KCC3 transfections 
Single copies of WT or AA human KCC3a cDNAs with an N-terminal myc 
epitope stably expressed under control of tetracycline were transfected into HEK-293 
cells using Flip-in T-Rex System (Invitrogen). In this study, doxycycline, a tetracycline 
derivative, was used to induce gene expression. 
 
3.5. Cell cultures 
Human embryonic kidney (HEK293) cells stably transfected with WT or AA 
KCC3a cDNAs were cultured in Dulbecco's Modified Eagle (DMEM) high glucose 
medium (Life Technologies, Catalog No.11965-092) supplemented with 10 % 
tetracycline-free fetal bovine serum (FBS) (Clontech, Catalog No.631106), 100 units/ml 
penicillin (Hyclone, Catalog No. SV30010), 100 µg/ml streptomycin (Hyclone, Catalog 
No. SV30010) and 10 µg/ml blasticidin S hydrochloride (Santa Cruz, Catalog No. sc-
204655) in a humidified incubator with 5 % CO2 at 37 
0
C. 
  
3.6. Ion Flux Studies  
Ion fluxes were determined according to previously published protocols (23, 35, 
37) with some modifications. Cells were grown to 60 % confluence in 12-well plates; 
KCC3 was expressed by overnight doxycycline (1µg/ml) induction. WT- or AA-treated 
cells were removed from the incubator, culture medium was aspirated, washed three times 
with 1ml 300 mOsM  BSS-NaCl or BSS-NaS and then equilibrated in BSS-BSA-NaCl or 
BSS-BSA-NaS, pH 7.4, 37 
0
C for 10 min, thereafter supernatants were removed and then 
exposed to pre-warmed actual flux media BSS-BSA-RbCl or BSS-BSA-RbS for pre-
determined time points (2.5 min to 15 min). Thereafter, cells were washed with washing 
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solution at room temperature to block Rb influx or Ki loss, cellular Rb and K were 
extracted after cell lysis by exposing for 15 min to ice cold 5 % PCA and finally protein 
was extracted by dissolving in 1 M NaOH. Rb and K were measured by atomic emission 
and absorption spectrophotometry, respectively using a Perkin Elmer 5000 atomic 
absorption spectrophotometer. Protein was determined by the BCA assay. Rb uptake or 
Ki loss was calculated in nmoles/mg protein as function of time. Ouabain (0.1 mM) and 
bumetanide (10 µM) were added to the flux media to block NKP and NKCC, 
respectively. Ouabain- and bumetanide-sensitive Rb influx in Cl was calculated as NKP 
and NKCC, respectively, whereas Cl-dependent Rb influx in presence of ouabain and 
bumetanide was determined as KCC.  
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4. Results 
4.1. Baseline Rb (K) influx components in KCC3 WT and AA cells 
 
Figure 5. Baseline Rb (K) influx components and transporters for WT and AA cells. 
Flux time was 5 min and Rb influx components and transporters were calculated as 
described in Materials and Methods. n = 9 for WT cells, and n = 6 for AA cells; values 
are means ± S.E. Details are discussed in the text. 
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Baseline NKP, NKCC and KCC were calculated by performing unidirectional 
uptake experiments using Rb as K congener in KCC3 WT- and AA-transfected HEK-293 
cells. The transporter activities were calculated as the Rb influx in (nmoles/mg protein) as 
shown in [Fig.5]. In WT cells, NKP and NKCC contributed to 90 % of the total Rb influx 
whereas only 10 % of influx occurred through KCC. The major contributor of the Rb 
influx was NKCC (50 %) followed by NKP (40 %). In AA cells, baseline NKCC activity 
was 58-60 % of the total Rb influx followed by NKP (28-30 %) and KCC (10-12 %), 
which are basically similar to the values observed in WT cells. Furthermore, under 
baseline conditions NKCC was the major component of Rb (K) influx in both WT and 
AA cells and was slightly more active in AA cells, whereas KCC activity was quite 
similar in both types of cells. 
4.2. Doxycycline-induced Rb (K) influx in WT and AA cells 
Rb influx was measured after overnight gene expression under doxycycline 
control. NKCC and KCC were calculated and results are shown in [Fig.6]. Doxycycline 
did not induce significant changes on NKCC and KCC activities in WT cells, whereas in 
AA cells, it induced a 25 fold increase in KCC activity. RbCl uptake was larger in the 
presence of ouabain and bumetanide compared to the uptake in the presence of ouabain 
alone and thus it resulted in calculated negative NKCC values, which have no physical 
meaning. 
4.3. Doxycycline-induced Rb (K) influx as function of time 
The doxycycline-induced RbCl uptake was calculated as a function of time in WT 
and AA cells and the results for 5 min flux are shown in [Fig.5]. Furthermore, in WT 
cells, NKCC and NKP activities were non-linear even at the earliest time point tested (i.e. 
2.5 min) whereas KCC activity was linear up to 15 min [Fig.7]. In AA cells, KCC activity 
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was non-linear and saturated at 10 min, whereas NKCC activity became more negative 
with increasing time (negative values have no physical meaning as discussed earlier) that 
could be due to an increase in Rb uptake in the presence of  bumetanide. 
 
 
Figure 6. NKCC and KCC in WT and AA cells before and after doxycycline 
induction. NKCC and KCC were calculated as the Cl-dependent ouabain-insensitive, 
bumetanide-sensitive and Cl-dependent (ouabain + bumetanide)-insensitive Rb influx 
(nmoles/mg protein x 5 min), respectively. n = 9 for WT cells and n = 4 for AA cells. 
Values are means ± S.E. Details are discussed in the text. 
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Figure 7. Rb uptake as function of time in WT and AA cells. Rb transporters NKP, 
NKCC and KCC were calculated as described in Materials and Methods. n = 9; values are 
means ± S.E. Details are discussed in the text. 
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4.4. Physiological factors affecting Rb influx in WT and AA cells  
To better understand the response of Rb (K) influx both in WT and AA mutants; 
we tested the effect of physiological factors such as external Na, serum and osmolality in 
these cells, [See Figs.  8, 9 and 10, respectively]. To assess the effect of external Na (Nao) 
on Rb influx, N-methyl D-glucamine (NMDG) was used as Na replacement. As expected, 
in both WT and AA cells the Na-dependent transporter NKCC was completely inhibited 
in Na-free medium, whereas KCC was not affected in WT cells. Interestingly, in AA 
cells, the doxycycline-induced KCC activity was reduced by 30 % in the absence of 
external Na. Furthermore, serum deprivation  for 24 h had no statistically significant 
effect on KCC activity under baseline  and doxycycline-induced conditions both in  WT 
and AA cells, in contrast to previous observations (36 and ref. therein), whereas NKCC 
was inhibited by 25 %  under baseline conditions and, as shown earlier, it was abolished 
in doxycycline-induced cells. In general, hypertonicity activates NKCC and inhibits KCC 
and hypotonicity inhibits NKCC and activates KCC. In WT cells, NKCC was activated 
by both hypertonicity and hypotonicity and KCC was unaffected (Fig. 10WT). This result 
could be outcome of variable ionic strength in flux media. In AA cells neither NKCC nor 
KCC was affected by changes in osmolality (Fig.10AA). This result was expected 
because permanently activated KCC3 is insensitive to changes in osmolality [22].     
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Figure 8. Rb influx in Na and Na-free (NMDG) medium in WT and AA cells. NKCC 
and KCC represent Rb influx in the absence of doxycycline, and DNKCC and DKCC 
represent Rb influx after overnight doxycycline induction. n = 6; values are ± S.E. Details 
are discussed in the text. 
 
Figure 9. Effect of serum deprivation on NKCC and KCC in WT and AA cells. 
NKCC and KCC are controls, DNKCC and DKCC in the presence of doxycycline. Flux 
time, 5 min; n = 4 for WT cells and n = 6 for AA cells. Values are means ± S.E. Details 
are discussed in the text. 
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Figure 10. Effect of tonicity on NKCC and KCC in WT and AA cells. Doxycycline 
induced NKCC and KCC activity in hypotonic (200 mOsM), isotonic (300 mOsM) and 
hypertonic (450 mOsM) flux media with variable ionic strength. Flux time 5 min. n = 6; 
values are means ± S.E. Details are discussed in the text. 
4.5. Intracellular K (K i) in WT and AA cells 
Figure.11. shows Ki in WT cells, when 15 min measured after exposure to Cl or S 
media in the presence of ouabain and of [ouabain + bumetanide]. Note that in S, there was 
a 30% Ki loss with respect to ClO or ClOB and was not affected by doxycycline 
treatment.  By definition, Ki loss in sulfamate indicates activation of a Cl-independent K 
loss mechanism. Surprisingly, induction of KCC3 by doxycycline in AA cells caused a 75 
%  Ki loss in Cl, 50 % of which was recovered by placing the cells in S medium, as 
shown in (Fig. 11 AA), indicating activation of a Cl-dependent Ki loss mechanisms 
through the KCC. Furthermore, increase in flux time from 2.5 min to 10 min increased 
the doxycycline-induced Cl-dependent K loss but no significant change was observed in 
the Cl-independent Ki loss (Fig. 12 AA). 
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Figure 11. Intracellular K content (Ki) in WT and AA cells for control and 
doxycycline-induced cells.  Ki after flux in 10 mM RbCl with 0.1 mM ouabain (ClO);  
with 0.1 mM ouabain + 10 µM bumetanide (ClOB); –and 10 mM RbS with 0.1 mM 
ouabain + 10 µM bumetanide (SOB). Flux time, 5 min; n = 9; values are means ± S.E. 
Details are discussed in the text. 
 
Figure 12. Time-course of Ki content in WT and AA cells in the absence and 
presence of doxycycline (D). Ki after flux in 10 mM RbCl, with 0.1 mM ouabain (ClO);  
with 0.1 mM ouabain + 10 µM bumetanide (ClOB); –and 10 mM RbS with 0.1 mM 
ouabain + 10 µM bumetanide (SOB). Flux time, 5 min; n = 9; values are means ± S.E. 
Details are discussed in the text. 
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This doxycycline-induced unidentified and significantly large Ki loss in isotonic 
conditions was not reported in any previous studies. So, we hypothesized that this Ki loss 
in AA cells under isotonic conditions could be the result of an imbalance in intracellular 
ion concentrations caused by the permanently activated KCC3AA. 
According to our hypothesis, doxycycline induces a Cl-dependent Ki loss through 
KCC matched by a significantly increased RbCl uptake caused by expression of the 
KCC3 mutant in HEK-293 cells. Doxycycline may also activate a Na channel such as the 
epithelial Na channel (ENaC) that transports Na into the cell, thus resulting in increased 
intracellular Na, leading to depolarization and swelling and consequently opening 
swelling-activated Cl (Clswell) and voltage-sensitive Ca channels, inducing Ca-activated 
Ca release from intracellular stores, and opening K and Cl channels (Fig.13). To test this 
hypothesis we have used ion replacement studies and several inhibitors of Cl, K and Ca 
channels (Fig. 14). The results will be discussed in the following sections. 
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Figure 13. Hypothetical model for doxycycline-induced K loss in KCC3 (AA) mutant 
cells 
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Figure 14. Approaches to inhibit K loss. The effectors/inhibitors in the diagram are: 
NMDG (Na replacement), Furo, furosemide, a KCC and anion channel blocker, DCPIB, a 
volume-sensitive Cl channel blocker, TEA/Clofilium, inhibitors of Ca-dependent and Ca-
independent channels, respectively, RR, Ruthenium Red, 1,2-Bis(2-aminophenoxy) 
ethane-N,N,N′,N′-tetra acetic acid (BAPTA), ethylene diamine tetra acetic acid (EDTA), 
Ca chelators, RN-1734, a selectiveTRPV4 channel blocker. 
 
4.6. Effect of extracellular K (Ko)on Ki loss in Na medium 
According to the Nernst equation, under physiological conditions, even a small 
rise in Ko leads to a more positive membrane potential and may result in depolarization. 
So, decrease or complete removal of Ko may lead to hyperpolarization and maintenance 
of Ki. To test this hypothesis, we have used 10 mM Rb, 5 mM K and 0 mM K/Rb flux 
media maintaining other components constant and the results are plotted in (Fig.  15). 
Results indicate inhibition of Cl-dependent Ki loss in 5 mM K and 0 mM K/Rb media but 
no effect on Ki loss in 10 mM Rb. The possible explanation for this inhibition of Ki loss 
in 5 mM K medium is bidirectional transport of K through KCC i.e. equal K influx and 
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efflux that, given the existent gradients, results in unchanged Ki whereas KCC inhibition 
by removal of extracellular K/Rb leads to inhibition of Cl-dependent Ki loss in 0 mM 
K/Rb medium which is not consistent with the loaded form of the carrier being rate 
limiting in sheep red cells [12]. 
 
Figure 15. Effect of extracellular K (Ko) on Ki in Na medium.  Ki in Cl with no 
inhibitors (Cl); ouabain (ClO); ouabain + bumetanide (ClOB); and in sulfamate (S) with 
ouabain + bumetanide (SOB). Flux time, 5 min. n=12; values are means ± S.E. Details 
are discussed in the text. 
 
4.7. Effect of extracellular K (Ko) on K i  loss in Na-free medium 
 
 According to our hypothesis, doxycycline induces an increase in intracellular Na 
by opening a Na channel, which may lead to depolarization and Ki loss. Replacing Nao 
with NMDG may preclude the Na-induced depolarization and consequently, the Ki loss. 
So, we have conducted experiments in NMDG under the same conditions described in the 
former section, i.e. 0 mM K/Rb, 5 mM K and 10 mM Rb flux media. In contrast to 
expectations, the results were essentially no different from those in Na medium, 
indicating either no or a partial role of Nao on doxycycline-induced Ki loss (Fig.16). 
Furthermore, inhibition of doxycycline-induced Cl-dependent Ki loss even in Na-free 
media at 0 mM K/Rb and 5 mM K confirmed the role of KCC in this process. 
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Figure 16. Effect of extracellular K (Ko) on Ki in Na-free medium. Na was replaced 
with NMDG. Ki in Cl, with no inhibitors (Cl); ouabain (ClO); ouabain + bumetanide 
(ClOB); and sulfamate (S) with ouabain + bumetanide (SOB). Flux time, 5 min. n=6; 
values are means ± S.E. Details are discussed in text. 
 
4.8. Effect of furosemide on Cl-dependent Ki loss 
 
 To further investigate the role of KCC in doxycycline-induced Ki loss, we have 
used 2 mM furosemide, an inhibitor of both NKCC, and KCC [43]. Furosemide, when 
used only during doxycycline induction had no effect on Ki loss but when used during 
both preincubation and flux inhibited doxycycline- induced Cl-dependent K loss although 
no effect was observed on Cl-independent Ki loss (Fig.17). As expected, furosemide also 
reduced RbCl uptake through KCC to baseline levels. In conclusion, the ion replacement 
studies and those with furosemide confirmed that doxycycline induced a Cl-dependent Ki 
loss through KCC. 
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Figure 17. Effect of 2 mM furosemide on Ki loss (K) and Rb influx (Rb). ClO and 
ClOB refer to Ki after flux in Cl with ouabain, or ouabain + bumetanide, respectively. 
SOB refers to Ki after flux in S with ouabain + bumetanide. D, doxycycline; furosemide; 
P, preincubation; fl, flux. n = 9; values are means ± S.E. Details are discussed in the text. 
 
4.9. Effect of TEA on K i loss 
 TEA, a blocker of Ca-dependent K channels inhibits the big conductance K 
channel (BK) at 2 mM and non-selectively other K channels at 10 mM. In addition, TEA 
inhibited Ki loss in several studies (9, 15). To block the massive doxycycline-induced K 
loss in AA cells, we used TEA at 2 mM during doxycycline induction alone, during 
induction and preincubation, or during induction, preincubation and flux. No effect of 
TEA at 2 mM was observed on Ki loss and Rb influx under any of the tested conditions 
implying that the BK channel was not responsible for the large Ki loss from AA cells 
(Fig.18). 
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Figure 18. Effect of TEA on Ki loss (K) and Rb influx (Rb). ClO and ClOB refer to Ki 
after flux in Cl with ouabain, or ouabain + bumetanide, respectively. SOB refers to Ki 
after flux in S with ouabain + bumetanide. D, doxycycline; P, preincubation; fl, flux. n = 
6; values are means ± S.E. Details discussed in the text. 
 
4.10. Effect of DCPIB on K i loss 
 DCPIB, a volume-sensitive Cl channel blocker, is known to inhibit Ki loss 
through IK channels in human lens epithelial cells [49]. DCPIB (50 µM) was used during 
either flux alone, pre-incubation and flux, or doxycycline induction, preincubation and 
flux. Complete inhibition of Ki loss was achieved in the latter condition where Ki was 
maintained at the control level. However, DCPIB also inhibited KCC by 50% (Fig. 19)  
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Figure 19. Effect of DCPIB on Ki loss (K) and Rb influx (Rb). ClO and ClOB refer to 
Ki after flux in Cl with ouabain, or ouabain + bumetanide, respectively. SOB refers to Ki 
after flux in S with ouabain + bumetanide. D, doxycycline; P, preincubation; fl, flux. n = 
6; values are means ± S.E. Details are discussed in the text. 
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5. Discussion 
 A recent study by Rinehart et al. [22] revealed the functional importance of two 
C-terminal threonine (T) phosphorylation sites; T991 and T1048 in KCC3 regulation. By 
assessing the increased Rb influx, they demonstrated that replacement of these two amino 
acids at 991 and 1048 with alanine leads to permanent activation of KCC3 under isotonic 
conditions. In this study, we investigated the importance of KCC3 and its two 
functionally important phosphorylation sites T991 and T1048 in Ki homeostasis, in a 
human epithelial cell line.  
By performing Rb influx studies and measuring Ki in WT- and AA-transfected 
HEK-293 cells, we have investigated the perturbed cellular K homeostasis in AA cells. In 
WT cells, neither KCC nor NKCC activity were affected by 16 h doxycycline induction 
whereas in AA cells, KCC increased by 25 fold, which is consistent with previous 
findings. NKCC was inhibited completely and negative (see Fig.6). This negative NKCC 
in AA cells needs to be further explored.  
In AA cells, doxycycline induction lead to a significant Ki loss (> 90 %) in Cl, and 
50 % of this loss was recovered in Cl-free medium, an effect not seen in WT cells, 
indicating that permanent activation of KCC3 altered K homeostasis. Partial inhibition of 
Ki loss in sulfamate medium shows that it has two components, a Cl-dependent and an 
unidentified Cl-independent Ki loss. The doxycycline-induced Cl-dependent K loss was 
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inhibited by replacing extracellular Rb with K, and by 2 mM furosemide (Fig. 12, 13, 14). 
This finding means that Ki loss occurred through KCC mediated K efflux. 
 Presence of numerous endogenous voltage-dependent Na, K, Ca and Cl channels, 
which can generate significant inward or outward currents has been reported for HEK-
293 cells in several previous studies (2, 4, 31, 51, 53). So, we attempted to inhibit the 
doxycycline-induced Cl-independent Ki loss by changing extracellular ion concentrations 
by ion replacement studies and by various K, Ca and Cl channel inhibitors. Changes in 
extracellular Na and K did not have any effect on the doxycycline-induced Cl-
independent Ki loss. The Ca-dependent K channel blocker TEA (2 mM), reported to 
block the big conductance (BK) channels in several studies, failed to inhibit the Cl-
independent Ki loss, excluding the role of BK channels in AA Ki loss. Clofilium tosylate 
(100 µM) another Ca-independent K channel blocker had no effect on Ki loss when used 
either during doxycycline induction alone or in addition to pre-incubation and flux (data 
not shown). Our experiments with Ca chelators such as EDTA, BAPTA and TRPV4 
channel blockers like RN-1734 are inconclusive. DCPIB (50 µM) a volume-sensitive Cl 
channel blocker when used during (doxycycline + pre-incubation + flux) completely 
inhibited the Ki loss. However, partial inhibition of KCC by DCPIB prevented us from 
concluding the role of volume-sensitive Cl channels in Ki loss. 
 In conclusion, expression of permanently activated KCC3 into HEK-293 cells 
under doxycycline control results in altered intracellular ion concentrations leading to Ki 
loss through Cl-dependent and Cl-independent pathways, indicating the importance of 
KCC3 in cellular K homeostasis. In addition, the Cl-independent K loss is insensitive to 
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TEA (2 mM), furosemide (2 mM) and to changes in Ko and Nao concentrations but 
sensitive to DCPIB (50 µM). 
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